| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proto-Oncogene Proteins c-akt | 8 | 2018 | 2073 | 1.210 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 3 | 2014 | 165 | 0.830 |
Why?
|
| Mutant Proteins | 2 | 2014 | 234 | 0.530 |
Why?
|
| Carcinoma, Renal Cell | 5 | 2017 | 2388 | 0.510 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2015 | 84 | 0.480 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2018 | 1710 | 0.410 |
Why?
|
| High-Throughput Screening Assays | 1 | 2012 | 205 | 0.360 |
Why?
|
| Drug Discovery | 1 | 2012 | 329 | 0.330 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2011 | 695 | 0.300 |
Why?
|
| Glucose | 1 | 2013 | 1220 | 0.280 |
Why?
|
| HeLa Cells | 3 | 2013 | 1685 | 0.240 |
Why?
|
| Autophagy | 4 | 2020 | 911 | 0.230 |
Why?
|
| Phosphorylation | 6 | 2018 | 4943 | 0.220 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2015 | 402 | 0.210 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 628 | 0.180 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2014 | 592 | 0.170 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2020 | 54 | 0.170 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2020 | 38 | 0.170 |
Why?
|
| Cell Line, Tumor | 11 | 2020 | 14838 | 0.170 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 2115 | 0.170 |
Why?
|
| STAT1 Transcription Factor | 1 | 2020 | 162 | 0.160 |
Why?
|
| Mice, Nude | 5 | 2020 | 4329 | 0.160 |
Why?
|
| Phosphofructokinase-1, Type C | 1 | 2018 | 21 | 0.150 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2017 | 41 | 0.150 |
Why?
|
| Kidney Neoplasms | 3 | 2017 | 3109 | 0.150 |
Why?
|
| Mad2 Proteins | 1 | 2017 | 33 | 0.150 |
Why?
|
| Signal Transduction | 8 | 2020 | 12102 | 0.140 |
Why?
|
| Cell Survival | 3 | 2013 | 3063 | 0.140 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2016 | 16 | 0.130 |
Why?
|
| B7-H1 Antigen | 2 | 2020 | 1089 | 0.130 |
Why?
|
| Neoplasms | 3 | 2020 | 15919 | 0.120 |
Why?
|
| Glycolysis | 1 | 2018 | 530 | 0.120 |
Why?
|
| Elongin | 1 | 2014 | 10 | 0.120 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2019 | 518 | 0.120 |
Why?
|
| Protein Binding | 5 | 2018 | 3485 | 0.120 |
Why?
|
| Protein Stability | 2 | 2012 | 377 | 0.120 |
Why?
|
| Isoelectric Focusing | 1 | 2013 | 52 | 0.110 |
Why?
|
| Enzyme Activation | 2 | 2018 | 1811 | 0.110 |
Why?
|
| Cyclin E | 1 | 2016 | 283 | 0.110 |
Why?
|
| Neoplasm Proteins | 2 | 2018 | 3346 | 0.110 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2013 | 19 | 0.110 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2013 | 52 | 0.110 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2013 | 71 | 0.110 |
Why?
|
| Citric Acid Cycle | 1 | 2013 | 92 | 0.110 |
Why?
|
| Cell Proliferation | 5 | 2019 | 7237 | 0.110 |
Why?
|
| Luminescent Measurements | 1 | 2013 | 158 | 0.110 |
Why?
|
| HCT116 Cells | 1 | 2013 | 354 | 0.100 |
Why?
|
| Immunoassay | 1 | 2013 | 214 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 269 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2016 | 2091 | 0.100 |
Why?
|
| Leupeptins | 1 | 2012 | 71 | 0.100 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2018 | 749 | 0.100 |
Why?
|
| HEK293 Cells | 2 | 2014 | 1462 | 0.100 |
Why?
|
| Cholestenone 5 alpha-Reductase | 1 | 2011 | 9 | 0.100 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2012 | 94 | 0.100 |
Why?
|
| Substrate Specificity | 1 | 2013 | 581 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2018 | 1469 | 0.100 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2019 | 1838 | 0.100 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2018 | 1013 | 0.100 |
Why?
|
| Animals | 11 | 2020 | 62048 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 341 | 0.090 |
Why?
|
| Protein Isoforms | 1 | 2013 | 848 | 0.090 |
Why?
|
| Humans | 20 | 2020 | 270802 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2013 | 295 | 0.090 |
Why?
|
| Proteasome Inhibitors | 1 | 2012 | 232 | 0.090 |
Why?
|
| RNA, Neoplasm | 1 | 2013 | 806 | 0.090 |
Why?
|
| Apoptosis | 4 | 2018 | 7754 | 0.090 |
Why?
|
| Cell Death | 1 | 2013 | 686 | 0.090 |
Why?
|
| Proteomics | 2 | 2018 | 1427 | 0.090 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 195 | 0.090 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 460 | 0.090 |
Why?
|
| Threonine | 1 | 2010 | 163 | 0.090 |
Why?
|
| Vimentin | 1 | 2010 | 255 | 0.080 |
Why?
|
| Androgens | 1 | 2011 | 508 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 526 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2018 | 1933 | 0.080 |
Why?
|
| Mesoderm | 1 | 2010 | 392 | 0.080 |
Why?
|
| Mutation, Missense | 1 | 2014 | 1193 | 0.080 |
Why?
|
| Mitochondria | 1 | 2015 | 1299 | 0.080 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 2196 | 0.080 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 1013 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 693 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2015 | 1267 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 469 | 0.070 |
Why?
|
| Chromatin | 1 | 2013 | 1046 | 0.070 |
Why?
|
| Carcinogenesis | 1 | 2014 | 1033 | 0.070 |
Why?
|
| Insulin | 1 | 2013 | 1486 | 0.070 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2018 | 1738 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2018 | 1776 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 2357 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2010 | 878 | 0.070 |
Why?
|
| Models, Biological | 1 | 2015 | 3194 | 0.070 |
Why?
|
| Mice | 6 | 2020 | 35597 | 0.070 |
Why?
|
| DNA-Binding Proteins | 2 | 2014 | 5002 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2007 | 299 | 0.060 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 226 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 1442 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 2453 | 0.060 |
Why?
|
| Heterografts | 2 | 2019 | 739 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2018 | 5403 | 0.060 |
Why?
|
| Genome, Human | 1 | 2013 | 1886 | 0.060 |
Why?
|
| Cell Line | 1 | 2012 | 5339 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2015 | 3031 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2018 | 9041 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 4961 | 0.060 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2010 | 916 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2013 | 2767 | 0.050 |
Why?
|
| Cell Movement | 1 | 2010 | 2472 | 0.050 |
Why?
|
| Mutation | 3 | 2013 | 15911 | 0.050 |
Why?
|
| Genomics | 1 | 2013 | 2836 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2013 | 9290 | 0.050 |
Why?
|
| Agrobacterium tumefaciens | 1 | 2001 | 8 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 6193 | 0.050 |
Why?
|
| Mice, SCID | 2 | 2019 | 1825 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 5149 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 4958 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2007 | 998 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 3439 | 0.050 |
Why?
|
| DNA Damage | 2 | 2019 | 1988 | 0.040 |
Why?
|
| RNA Interference | 2 | 2015 | 1387 | 0.040 |
Why?
|
| Fibroblasts | 2 | 2017 | 1656 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2001 | 266 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2013 | 2886 | 0.040 |
Why?
|
| Ion Channels | 1 | 2001 | 235 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2014 | 5440 | 0.040 |
Why?
|
| Photosensitizing Agents | 1 | 2020 | 82 | 0.040 |
Why?
|
| Sarcoma | 1 | 2010 | 1838 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 3656 | 0.040 |
Why?
|
| G2 Phase Cell Cycle Checkpoints | 1 | 2019 | 78 | 0.040 |
Why?
|
| Lysine Acetyltransferase 5 | 1 | 2018 | 16 | 0.040 |
Why?
|
| Fructosediphosphates | 1 | 2018 | 12 | 0.040 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2018 | 28 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 7103 | 0.040 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2018 | 57 | 0.040 |
Why?
|
| Phosphofructokinase-2 | 1 | 2018 | 36 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2017 | 5698 | 0.040 |
Why?
|
| Oncogene Protein v-akt | 1 | 2018 | 101 | 0.040 |
Why?
|
| src Homology Domains | 1 | 2018 | 133 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 191 | 0.040 |
Why?
|
| Biomarkers, Tumor | 2 | 2015 | 10706 | 0.030 |
Why?
|
| Acetylation | 1 | 2018 | 514 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 16669 | 0.030 |
Why?
|
| Mitosis | 1 | 2019 | 680 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 3919 | 0.030 |
Why?
|
| Chromosomal Instability | 1 | 2017 | 229 | 0.030 |
Why?
|
| Aneuploidy | 1 | 2017 | 381 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2016 | 72 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 7383 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 14616 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2001 | 1092 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 5860 | 0.030 |
Why?
|
| Sequestosome-1 Protein | 1 | 2014 | 39 | 0.030 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2014 | 35 | 0.030 |
Why?
|
| Beclin-1 | 1 | 2014 | 88 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 547 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2017 | 747 | 0.030 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2014 | 59 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 2455 | 0.030 |
Why?
|
| Plasmids | 1 | 2015 | 936 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 3532 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2019 | 2033 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2015 | 427 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 2014 | 2929 | 0.030 |
Why?
|
| Antibodies | 1 | 2015 | 809 | 0.030 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2011 | 21 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2015 | 593 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 1554 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 2011 | 94 | 0.020 |
Why?
|
| Dactinomycin | 1 | 2011 | 163 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 1542 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2017 | 2137 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 16205 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2014 | 622 | 0.020 |
Why?
|
| Response Elements | 1 | 2011 | 192 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 399 | 0.020 |
Why?
|
| Bevacizumab | 1 | 2015 | 967 | 0.020 |
Why?
|
| Pyrroles | 1 | 2015 | 589 | 0.020 |
Why?
|
| Serine | 1 | 2012 | 391 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 714 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2015 | 1473 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2011 | 737 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2015 | 1052 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2012 | 588 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2015 | 1032 | 0.020 |
Why?
|
| Indoles | 1 | 2015 | 1028 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2018 | 2376 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2011 | 651 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 3341 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 589 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 2422 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 1121 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 809 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 5759 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 1655 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 3944 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2011 | 854 | 0.020 |
Why?
|
| Kidney | 1 | 2014 | 2121 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 13021 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 3118 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 3588 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 3215 | 0.010 |
Why?
|
| Female | 3 | 2020 | 148967 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 4048 | 0.010 |
Why?
|
| Magnoliopsida | 1 | 2001 | 10 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 6398 | 0.010 |
Why?
|
| Plant Leaves | 1 | 2001 | 60 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2001 | 1028 | 0.010 |
Why?
|
| Binding Sites | 1 | 2001 | 2256 | 0.010 |
Why?
|
| Male | 2 | 2018 | 128397 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 4569 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 6686 | 0.010 |
Why?
|